FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912509330> ?p ?o ?g. }

• W2912509330 endingPage "81" @default.
• W2912509330 startingPage "73" @default.
• W2912509330 abstract "Amyotrophic lateral sclerosis (ALS) is a chronic degenerative disease that mainly affects motor neurons, leading to progressive paralysis and death. Recently, cell therapy has emerged as a therapeutic alternative for several neurological diseases, including ALS, and bone-marrow cells are one of the major cell sources. Considering the importance of pre-clinical trials to determine the best therapeutic protocol and the hope of translating this protocol to the clinical setting, we tested bone-marrow mononuclear cell (BMMC) therapy administered by different routes in the SOD1G93A model of ALS. BMMCs were isolated from non-transgenic, age matched animals and administered intravenously (IV), intramuscularly (IM), and intravenously and intramuscular concomitantly (IV + IM). BMMC therapy had no significant beneficial effects when injected IV or IM, but delayed disease progression when these two routes were used concomitantly. BMMC IV + IM treatment reduced the number of microglia cells in the spinal cord and partially protected of neuromuscular-junction innervation, but had no effect in preventing motor-neuron loss. This study showed that injection of BMMC IV + IM had better results when compared to each route in isolation, highlighting the importance of targeting multiple anatomical regions in the treatment of ALS." @default.
• W2912509330 created "2019-02-21" @default.
• W2912509330 creator A5023816656 @default.
• W2912509330 creator A5047409545 @default.
• W2912509330 creator A5049740267 @default.
• W2912509330 creator A5072673091 @default.
• W2912509330 creator A5077666601 @default.
• W2912509330 creator A5080608076 @default.
• W2912509330 creator A5090239278 @default.
• W2912509330 date "2019-06-01" @default.
• W2912509330 modified "2023-09-25" @default.
• W2912509330 title "Bone-marrow mononuclear cell therapy in a mouse model of amyotrophic lateral sclerosis: Functional outcomes from different administration routes" @default.
• W2912509330 cites W1493853215 @default.
• W2912509330 cites W1601534163 @default.
• W2912509330 cites W1698980491 @default.
• W2912509330 cites W1801150000 @default.
• W2912509330 cites W1976266513 @default.
• W2912509330 cites W1979043688 @default.
• W2912509330 cites W1979432108 @default.
• W2912509330 cites W1982938145 @default.
• W2912509330 cites W1990920498 @default.
• W2912509330 cites W2015074345 @default.
• W2912509330 cites W2016879629 @default.
• W2912509330 cites W2017678299 @default.
• W2912509330 cites W2040891140 @default.
• W2912509330 cites W2041487464 @default.
• W2912509330 cites W2049958331 @default.
• W2912509330 cites W2063549569 @default.
• W2912509330 cites W2065055552 @default.
• W2912509330 cites W2066259320 @default.
• W2912509330 cites W2066828509 @default.
• W2912509330 cites W206771037 @default.
• W2912509330 cites W2069681400 @default.
• W2912509330 cites W2070542281 @default.
• W2912509330 cites W2071768899 @default.
• W2912509330 cites W2089592211 @default.
• W2912509330 cites W2092312715 @default.
• W2912509330 cites W2096386031 @default.
• W2912509330 cites W2099759772 @default.
• W2912509330 cites W2106117542 @default.
• W2912509330 cites W2106306006 @default.
• W2912509330 cites W2106456867 @default.
• W2912509330 cites W2121500739 @default.
• W2912509330 cites W2123991169 @default.
• W2912509330 cites W2124705393 @default.
• W2912509330 cites W2128084057 @default.
• W2912509330 cites W2155137515 @default.
• W2912509330 cites W2156248333 @default.
• W2912509330 cites W2156969855 @default.
• W2912509330 cites W2208065203 @default.
• W2912509330 cites W2299689687 @default.
• W2912509330 cites W2318202546 @default.
• W2912509330 cites W2333242012 @default.
• W2912509330 cites W2521748846 @default.
• W2912509330 cites W2539567223 @default.
• W2912509330 cites W2607420694 @default.
• W2912509330 doi "https://doi.org/10.1016/j.brainres.2019.02.003" @default.
• W2912509330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30735638" @default.
• W2912509330 hasPublicationYear "2019" @default.
• W2912509330 type Work @default.
• W2912509330 sameAs 2912509330 @default.
• W2912509330 citedByCount "9" @default.
• W2912509330 countsByYear W29125093302020 @default.
• W2912509330 countsByYear W29125093302021 @default.
• W2912509330 countsByYear W29125093302022 @default.
• W2912509330 crossrefType "journal-article" @default.
• W2912509330 hasAuthorship W2912509330A5023816656 @default.
• W2912509330 hasAuthorship W2912509330A5047409545 @default.
• W2912509330 hasAuthorship W2912509330A5049740267 @default.
• W2912509330 hasAuthorship W2912509330A5072673091 @default.
• W2912509330 hasAuthorship W2912509330A5077666601 @default.
• W2912509330 hasAuthorship W2912509330A5080608076 @default.
• W2912509330 hasAuthorship W2912509330A5090239278 @default.
• W2912509330 hasConcept C104317684 @default.
• W2912509330 hasConcept C10882517 @default.
• W2912509330 hasConcept C111599444 @default.
• W2912509330 hasConcept C118552586 @default.
• W2912509330 hasConcept C126322002 @default.
• W2912509330 hasConcept C137061746 @default.
• W2912509330 hasConcept C141071460 @default.
• W2912509330 hasConcept C142724271 @default.
• W2912509330 hasConcept C1491633281 @default.
• W2912509330 hasConcept C198826908 @default.
• W2912509330 hasConcept C202751555 @default.
• W2912509330 hasConcept C2776752467 @default.
• W2912509330 hasConcept C2776914184 @default.
• W2912509330 hasConcept C2779134260 @default.
• W2912509330 hasConcept C2779389132 @default.
• W2912509330 hasConcept C2779618896 @default.
• W2912509330 hasConcept C2779830541 @default.
• W2912509330 hasConcept C2780007613 @default.
• W2912509330 hasConcept C2780596555 @default.
• W2912509330 hasConcept C2780775167 @default.
• W2912509330 hasConcept C535046627 @default.
• W2912509330 hasConcept C54355233 @default.
• W2912509330 hasConcept C55493867 @default.
• W2912509330 hasConcept C71924100 @default.
• W2912509330 hasConcept C86803240 @default.

• next